FDA Approves First Nalmefene Hydrochloride Auto-Injector to Reverse Opioid Overdose
FDA News Release Agency Continues to Support Development of Overdose Reversal Drugs including Naloxone and Nalmefene For Immediate Release: August 07, 2024 Today, the U.S. Food and Drug Administration approved Zurnai, the first nalmefene hydrochloride auto …